(19)
(11) EP 4 106 801 A1

(12)

(43) Date of publication:
28.12.2022 Bulletin 2022/52

(21) Application number: 21712896.6

(22) Date of filing: 17.02.2021
(51) International Patent Classification (IPC): 
A61K 38/47(2006.01)
C12N 9/24(2006.01)
C12N 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/2402; C12N 9/1051; A61K 38/00
(86) International application number:
PCT/IB2021/051322
(87) International publication number:
WO 2021/165841 (26.08.2021 Gazette 2021/34)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.02.2020 IT 202000003371

(71) Applicants:
  • Agenzia Nazionale Per Le Nuove Tecnologie, L'Energia E Lo Sviluppo Economico Sostenibile (ENEA)
    00196 Roma (IT)
  • AIG Associazione Italiana Glicogenosi
    20090 Assago (MI) (IT)

(72) Inventors:
  • FRANCONI, Rosella
    00061 Anguillara Sabazia (Roma) (IT)
  • GIULIANO, Giovanni
    00165 Roma (IT)
  • MARINO, Carmela
    00135 Roma (IT)
  • DEMURTAS, Olivia Costantina
    00063 Campagnano di Roma (Roma) (IT)
  • TRIGGIANI, Doriana
    00063 Campagnano di Roma (Roma) (IT)

(74) Representative: Biggi, Cristina 
Bugnion S.p.A. Viale Lancetti 17
20158 Milano
20158 Milano (IT)

   


(54) COMPOUND FOR THE TREATMENT OF A GLYCOGENOSIS